AstraZeneca Finalizes Equity Investment, Research Collaboration with Cellectis

1 min read

Joint venture aims to develop up to 10 new cell and gene therapy products targeting areas with high unmet medical needs.

You May Also Like

More From Author

+ There are no comments

Add yours